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Experimental infection with the protozoan parasite Leishmania major has been extensively 
used to understand the mechanisms involved in T helper cell differentiation. Following 
infection, C57BL/6 mice develop a small self-healing cutaneous lesion and they are able 
to control parasite burden, a process linked to the development of T helper (Th) 1 cells. 
The local presence of IL-12 has been reported to be critical in driving Th1 cell differen-
tiation. In addition, the early secretion of IL-4 was reported to potentially contribute to 
Th1 cell differentiation. Following infection with L. major, early keratinocyte-derived IL-4 
was suggested to contribute to Th1 cell differentiation. To investigate a putative autocrine 
role of IL-4 signaling on keratinocytes at the site of infection, we generated C57BL/6 
mice deficient for IL-4Rα expression selectively in keratinocytes. Upon infection with 
L. major, these mice could control their inflammatory lesion and parasite load correlating 
with the development of Th1 effector cells. These data demonstrate that IL-4 signaling 
on keratinocytes does not contribute to Th1 cell differentiation. To further investigate the 
source of IL-4 in the skin during the first days after L. major infection, we used C57BL/6 
IL-4 reporter mice allowing the visualization of IL-4 mRNA expression and protein pro-
duction. These mice were infected with L. major. During the first 3 days after infection, 
skin IL-4 mRNA expression was observed selectively in mast cells. However, no IL-4 
protein production was detectable locally. In addition, early IL-4 blockade locally had no 
impact on subsequent Th1 cell differentiation and control of the disease. Taken together, 
the present data rule out a major role for skin IL-4 and keratinocyte IL-4Rα signaling in 
the development of a Th1 protective immune response following experimental infection 
with L. major.
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inTrODUcTiOn
Upon infection, Leishmania protozoan parasites can cause a 
spectrum of diseases ranging from cutaneous, muco-cutaneous 
to visceral forms. Following Leishmania major experimental 
infection, C57BL/6 mice develop a small cutaneous lesion that is 
self-healing. Healing of lesion and control of parasite load were 
shown to result from the differentiation of CD4+ T helper (Th) 
1 cells characterized by their secretion of high levels of IFNγ, 
a cytokine promoting the differentiation of M1 macrophages that 
kill intracellular parasites. In contrast, following L. major infec-
tion, BALB/c mice develop non-healing lesions and are not able to 
control their parasite load. This phenotype was shown to correlate 
with the development of CD4+ Th2 cells secreting IL-4 and IL-13 
cytokines (1, 2). These cytokines induce the differentiation of M2 
macrophages that favor parasite survival within macrophages 
(3). The L. major experimental model was the first murine model 
demonstrating that the discovery of Th1 and Th2 cells subsets by 
Mosmann et al. in vitro (4) had some relevance in vivo.
It is well established that the IL-12 produced by antigen 
presenting cells (APC) is necessary to launch the differentiation 
of CD4+ Th1  cells that protect against intracellular pathogens, 
including Leishmania (5). In contrast the role of IL-4 in L. major 
susceptibility and Th2 cell differentiation is more controversial. 
Following infection with L. major (LV39), IL-4−/− or IL-4Rα−/− 
mice on a BALB/c genetic background were able to control lesion 
size and the levels of IFNγ present in draining lymph node (dLN) 
cells was either very low or remained unchanged compared to 
that observed in BALB/c wild-type mice (6, 7). These data sug-
gested that IL-4 was critical for L. major susceptibility and Th2 
cell differentiation. The C57Bl/6x129 IL-4−/− mice used in these 
studies were backcrossed for six generations onto the BALB/c 
genetic background. In contrast, following infection with 
L. major LV39 IL-4−/− mice generated with embryonic stem cells 
of BALB/c origin still developed progressive non-healing lesions 
that were comparable to those of similarly infected wild-type 
BALB/c mice (8). Infection of these mice with another strain 
of L. major (IR173) resulted in partial control of lesion size in 
IL-4−/− mice, while IL-4Rα−/− controlled lesion size efficiently (9). 
Additional studies using IL-4 or IL-4Rα-deficient mice showed 
that following infection with L. major Th2 differentiation could 
develop in absence of IL-4 (10–12). Specific deletion of IL-4Rα 
signaling on T cells resulted in a healing phenotype in BALB/c 
mice associated with increased IFNγ response, suggesting a role 
for IL-4 and IL-13 in susceptibility following L. major infection 
(13). Collectively, these results indicated that along with IL-4, 
IL-13, and other factors are involved in the control of Th2 cell 
differentiation and L. major susceptibility (14).
In addition, several lines of evidence suggest that IL-4 may 
be needed for Th1 cell differentiation. Unlike what was observed 
following L. major infection, IL-4-deficient mice failed to develop 
Th1  cells in response to infection with Candida albicans (15) 
suggesting a potential role for endogenous IL-4 in Th1 cell dif-
ferentiation and protective antifungal response. Furthermore, 
local injection of exogenous recombinant IL-4 within the first 8 h 
of L. major infection in BALB/c mice was sufficient to modify 
the development of the immune response from an otherwise Th2 
immune response into a protective type-1 Th1 response (16). 
It was hypothesized that IL-4, by acting on dendritic cells, 
induced their IL-12 secretion (16), a process that had previously 
been reported on macrophages and DCs in vitro (17–19). In addi-
tion, dendritic cell-specific IL-4Rα-deficient mice on the BALB/c 
genetic background developed larger lesions and increased 
Th2 response, suggesting some protective role for endogenous 
IL-4 acting on DCs during L. major LV39 and IL-81 infection 
(20). Collectively, these studies suggested that within the first 
hours of L. major infection the transient presence of IL-4 could 
contribute to the differentiation of CD4+ Th1 cells. In this line, 
skin keratinocytes present in the footpad of mice infected with 
L. major subcutaneously were identified as an early IL-4 source 
contributing to the launching of CD4+ Th1  cell differentiation 
(21). Interestingly, in that study, IL-4 transcription appeared 
restricted to keratinocytes from C57BL/6 mice and only low IL-4 
mRNA levels were observed in BALB/c keratinocytes. Moreover, 
in the same study, the upregulation of IL-4 mRNA observed in 
C57BL/6 keratinocytes was shown to be restricted to a very small 
time window at the onset of infection. Finally, impaired Th1 cell 
development was observed in C57BL/6 mice following blocking 
of IL-4 protein with an anti-IL-4 mAb at the cutaneous infection 
site (21). Targeting IL-4 at the infection site could be of potential 
interest in the design of vaccines.
Here, we investigated the role of skin IL-4Rα signaling, 
more specifically the contribution of keratinocyte-derived 
IL-4Rα signaling during the first days of L. major infection 
and its subsequent impact on the development of a protective 
type-1 immune response in C57BL/6 mice. To this end, we 
generated C57BL/6 mice specifically deficient in IL-4Rα in their 
keratinocytes (KRT14CreIL-4Rα−/lox). As IL-4 and IL-13 share a 
common signaling pathway through the IL-4Rα the combined 
role of both cytokines could be studied in these mice. Following 
infection with L. major in the ear dermis or subcutaneously in 
the footpad, these mice were fully able to control their lesion 
size and develop Th1  cells. Furthermore, using IL-4 reporter 
mice, we identified mast cells as the only skin cells transcribing 
but not producing IL-4 in C57BL/6 skin early in infection. Our 
data demonstrate that the presence of IL-4 and IL-4 signaling 
in the skin during the first days after L. major infection are 
not required for the development of a protective Th1 immune 
response in C57BL/6 mice.
MaTerials anD MeThODs
Mice
C57BL/6 mice were purchased from Charles Rivers. 4get, and 
KN2 mice (22, 23) were a gift from Markus Mohrs, Trudeau 
Institute, USA. Keratinocyte cell-specific 4get/KN2 mice were 
obtained by the breeding of 4get and KN2 mice. IL-4Rα-deficient 
(KRT14creIL-4Rα−/lox) mice on the C57BL/6 genetic background 
were generated using the Cre/loxP system. Briefly, KRT14cre 
mice on the BALB/c genetic background (Jackson Laboratory) 
were first backcrossed on the C57BL/6 genetic background for 
nine generations. The progeny were crossed with IL-4Rα−/− 
C57BL/6 mice and transgenic IL-4Rαlox/lox mice (24) to generate 
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hemizygous KRT14creIL-4Rα−/lox C57BL/6 mice. Genotyping of 
KRT14creIL-4Rα−/lox C57BL/6 mice was performed using specific 
primers: KRT14 P1, 5’- TTC CTC AGG AGT GTC TTC GC; 
KRT14 P2, 5’- GTC CAT GTC CTT CCT GAA GC; KRT14 P3, 
5’- CAA ATG TTG CTT GTC TGG TG; KRT14 P4, 5’- GTC AGT 
CGA GTG CAC AGT TT. Characterization was also performed 
by flow cytometry using the anti-IL-4Rα mAb [anti-CD124, 
anti-IL-4Rα-PE from (BD, Pharmingen)]. Mice were bred under 
pathogen-free conditions at the Epalinges Center. 5- to 8-week-
old females were used.
ethics approval
All animal experimental protocols were approved by the veterinary 
office regulations of the State of Vaud, Switzerland, authorization 
1266.6-7 to FTC and performed in compliance with Swiss ethics 
laws for animal protection. All mouse experiments performed at 
the University of Cape Town were performed in strict accordance 
with the South African national guidelines, as well as the Animal 
Research Ethics Committee of the Faculty of Health Sciences, 
University of Cape Town (license no. 015/034). All efforts were 
made to minimize and reduce suffering of animals.
Parasites and infections
Leishmania major (LV39, MRHO/Sv/59/P strain) or in selected 
experiments GFP-expressing L. major IL-81 (MHOM/IL/81/
FEBNI) parasites were cultured at 26°C in complete M199 
medium (10% fetal bovine serum, 4% HEPES, 1% penicillin, 
streptomycin, and neomycin). 104 or 2 × 105 L. major metacyclic 
promastigotes were prepared from confluent stationary phase 
promastigotes by Ficoll gradient density centrifugation as pre-
viously described (25) and injected in the ear dermis or footpad. 
Lesion development was monitored using Vernier caliper, ear 
lesion diameter was measured for intradermal infection. For 
IL-4 depletion, 2  ×  105 metacyclic parasites (±1  µg 11B11 
antibody) were needle injected into the ear dermis in iDMEM 
in a final volume of 10 µL, or in the hind footpad in a volume 
of 50  µL. Four hours later, 1  µg of 11B11 mAb was injected 
intradermally (i.d.) in a final volume of 10 µL. For the induction 
of a Th2 response in C57BL/6 4get/KN2 mice, 1 mg of αIFNγ 
(XMG1.2) and αIL-12 were injected intraperitoneally 24, 2 h 
prior and 48 h post intradermal infection of 2 × 105 L. major 
metacyclic promastigotes.
Determination of antibody response
Leishmania major-specific IgG1 and IgG2c levels were deter-
mined by ELISA in the sera of mice harvested at the termination 
of the experiment, as previously described (26), Biotinylated 
goat anti-mouse IgG2c (Southern Biotech) and biotinylated rat 
anti-mouse IgG1 (BD Pharmingen) were used. Plates were read 
at the optical density of 490 nm. Titration curve were performed 
for all samples.
isolation of dln, spleen, and ear Mouse 
cells
Infected ears, spleen, and dLNs were isolated and processed to 
single cell suspensions. Briefly, ears were recovered, homogenized 
in iDMEM containing 0.2 mg/mL Liberase TL (Roche) for 2 h 
at 37°C and then homogenized and filtered using 40-µm filters 
(Falcon). dLN and spleen cells were isolated, homogenized, and 
stained for flow cytometry analysis. For intracellular cytokine 
staining, 1 × 106 dLN cells were stimulated with 50 µg/mL PMA, 
500  µg/mL Ionomycin, and 1  µg/mL Brefeldin A for 4  h prior 
staining. Live parasites were determined by limiting dilution 
assay (LDA) as described previously (27).
cytokine Production
106 dLN cells were cultured in presence or absence of UV- 
irradiated stationary phase parasites (parasites were exposed to UV.C 
for 3 min, at a distance of 10 cm from the UV lamp) L. major promas-
tigotes (MOI of 5:1) for 72 h at 37°C. Supernatants were recovered 
and IL-4 production measured by ELISA following manufacturer’s 
instructions (BD Biosciences; R&D). IFNγ secretion was detected 
using a homemade ELISA kit as previously described (28).
Derivation of Mouse Primary 
Keratinocytes
Primary keratinocytes were isolated from the skin of adult mice 
tail. Briefly, the skin from the tail was collected and incubated 
at 4°C for 16 h in a solution of 5 U/mL Dispase (STEMCELL) 
supplemented with 1% PNS (Gibco) and 0.5% Gentamicin 
(Gibco). The epidermis was separated from the dermis and 
treated with 0.2% trypsin (Gibco) for 5 min at 37°C. The reaction 
was stopped with FCS, and cells were collected by crushing the 
epidermis with a 100-µm cell strainer (Falcon). 7.5 × 105 cells/
mL were plated in a 6-well plate coated with Type I collagen 
(STEMCELL). Cells were grown for 8 days at 37°C in CnT-57.S 
medium (CELLnTEC) supplemented with 1% PNS and 0.5% 
Gentamicin. Medium were removed and cells detached with 
200 µL 0.2% trypsin for 5 min at 37°C. Cells were counted and 
plated at 0.3 × 106 cells/mL in a 96-well plate coated with Type 
I collagen.
Flow cytometry
Stained cells were analyzed using a BD LSR II-SORP or Fortessa 
system (Becton Dickinson) and analyzed with FlowJo soft-
ware (Tree Star). The following anti-mouse mAbs were used: 
CD45- PerCPCy5, CD45-APC, CD8-APC, anti-IFNγ-PECy7, 
and anti-IL-4-FITC (BD Biosciences), CD4-AF700, CD11b 
APC-eFluor780, and c-kit PECy7 all from (eBiosciences). Anti 
human CD2 (BioLegend) was used to detect IL-4 production 
in KN2 mice. To detect IL-4Rα on primary keratinocytes, the 
following anti-mouse mAbs were used: CD124, anti IL-4Rα-PE 
(BD, Pharmingen), and CD49f-Brillant Violet 421 (BioLegend). 
Imaging flow cytometry was performed using an ImageStream 
cytometer (Amnis, Millipore) at low speed. Data were analyzed 
with the IDEAS software.
statistics
All p values were determined with Prism software (GraphPad 
Software, Inc.) using the Student’s t-test for unpaired data or 
paired data, following prior testing for normal distribution. The 
degree of significance was indicated as *p < 0.05, **p < 0.01, and 
***p < 0.001.
FigUre 1 | Characterization of KRT14creIL-4Rα−/lox C57BL/6 mice. (a) Genotyping of KRT14creIL-4Rα−/lox mice, IL-4Rα−/lox, IL-4Rα+/+, IL-4Rαlox/lox, and negative 
control (H2O) is shown. The yielded PCR products in base pairs are indicated in the figure. (B) IL-4Rα cell surface expression was analyzed by flow cytometry on 
primary keratinocytes of the indicated mice. (c) IL-4Rα expression was analyzed in splenic CD4+ T cells (A), CD19+ B cells (B) and F480+ (C) macrophages of the 
indicated mice. Data shown are representative of three independent experiments.
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resUlTs
absence of il-4rα signaling in 
Keratinocytes Does not Prevent the 
Development of a Protective Type-1 
immune response
To investigate the impact of IL-4Rα signaling on keratinocytes in 
a protective Th1 cell differentiation against cutaneous leishma-
niasis, we generated mice on the C57BL/6 genetic background 
that are genetically deficient in IL-4Rα expression on keratino-
cytes (KRT14CreIL-4Rα−/lox) using the Cre/LoxP recombina-
tion system under control of the KRT14 locus. In these mice, 
keratinocytes cannot respond to IL-4 and IL-13, while other 
cells can. The absence of skin IL-4Rα expression was verified 
by PCR of naïve ears. KRT14CreIL-4Rα−/lox expressed both the 
deleted and WT IL-4Rα allele in addition to the LoxP and Cre 
bands. The genotype was also validated for IL-4Rα−/lox, IL-4Rα+/+ 
(C57BL/6 wild type) control mice as well as for IL-4−/− on the 
C57BL/6 genetic background (Figure 1A). The selective absence 
of IL-4Rα on KRT14CreIL-4Rα−/lox keratinocytes was further 
analyzed by flow cytometry on primary keratinocytes derived 
from the skin of these mice. IL-4Rα expression was not detected 
on CD45−CD49f+ keratinocytes of KRT14CreIL-4Rα−/lox mice. 
As controls, expression of IL-4Rα was detected on keratinocytes 
of wild-type C57BL/6 mice and was absent on keratinocytes of 
IL-4Rα−/− mice (Figure 1B). As expected, expression of IL-4Rα 
was, however, detected in splenic CD4+ T cells, CD19+ B cells, and 
F480+ macrophages of KRT14CreIL-4Rα−/lox mice (Figure  1C). 
The slightly lower IL-4Rα surface expression levels observed 
in KRT14CreIL-4Rα−/lox CD4+ T  cells, CD19+ B  cells and F480+ 
macrophages compared to those observed in C57BL/6 wild-type 
cells are in line with the IL-4Rα−/lox genotype of the control mice. 
No IL-4Rα expression was observed in IL-4Rα−/− CD4+ T cells 
and CD19+ B cells. These data show that KRT14CreIL-4Rα−/lox mice 
do not express IL-4Rα selectively on keratinocytes.
To investigate if IL-4Rα signaling in keratinocytes could have an 
impact on the local microenvironment driving Th1 differentiation 
FigUre 2 | Mice on a C57BL/6 genetic background that are deficient for IL-4Rα in their keratinocytes or on all cells are fully able to control their lesion size and 
parasite load following s.c. or i.d. Leishmania major infection. (a) KRT14creIL-4Rα−/lox, IL-4Rα−/lox, C57BL/6, and IL-4Rα−/− mice were infected s.c. with 2 × 105 
metacyclic L. major LV39 and lesion size was monitored. (B) Parasite load in draining lymph nodes (dLNs) and (c) spleen was analyzed by limiting dilution assays 
(LDAs) 8 weeks postinfection. (D) The indicated mice were infected in the ear dermis with 104 L. major and lesion development monitored. (e) Parasite load in the 
dLN or (F) spleen was analyzed by LDAs 7 weeks postinfection **p < 0.01 ***p < 0.001 compared to BALB/c. *p < 0,05 C57BL/6 compared to IL-4Rα−/lox, 
IL-4Rα−/−, and KRT14creIL-4Rα−/lox. These data are representative of two independent experiments.
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during L. major infection, KRT14CreIL-4Rα−/lox on the C57BL/6 
genetic background were infected subcutaneously in the footpad 
with 2 × 105 L. major. Lesion development and parasite load in the 
dLNs and spleen were analyzed and compared to lesion develop-
ing in control IL-4Rα−/lox, IL-4Rα+/+, and IL-4Rα−/− mice all on the 
C57BL/6 genetic background. L. major susceptible BALB/c mice 
were similarly infected and used for comparison. No difference in 
lesion development was observed between all groups of mice on 
the C57BL/6 genetic background, and BALB/c mice developed 
a significantly larger lesion (Figure 2A). Parasite load was also 
similar in the dLNs of these mice and no parasite dissemination to 
the spleen was observed, while significantly higher dLN parasite 
load and the presence of parasite dissemination to the spleen were 
observed in BALB/c mice (Figures 2B,C). Phlebotomine sand flies 
deposit significantly lower dose of parasites in the mammalian 
dermis, and it was previously reported that the cellular recruit-
ment differ between subcutaneous infection in the footpad or 
intradermal infection in mouse ear dermis (29). To assess a poten-
tial role for IL-4Rα signaling in keratinocytes on disease outcome 
in more physiological conditions, we needle inoculated mice with 
1 × 104 L. major LV39 metacyclic parasites, in the ear dermis of 
KRT14CreIL-4Rα−/lox mice. Lesion development and parasite load 
were compared to those observed in similarly infected IL-4Rα−/lox, 
IL-4Rα−/− mice, IL-4Rα+/+ mice all on the C57BL/6 genetic back-
ground. No difference in lesion size was observed in all groups of 
mice. In contrast, similarly infected BALB/c mice developed non-
healing lesions (Figure 2D). All groups of mice on the C57BL/6 
genetic background also controlled parasite load as assessed in 
the dLN and no parasite dissemination to the spleen was observed 
while similarly infected BALB/c mice showed higher parasite load 
in dLN and parasite disseminated to the spleen (Figures 2E,F). 
These data demonstrate that IL-4Rα signaling in keratinocytes 
is not required for control of lesion development and parasite 
burden. In addition, total lack of IL-4Rα signaling did not have an 
impact on the resolution of the infection. The control of parasite 
load in KRT14CreIL-4Rα−/lox and IL-4Rα−/− mice suggested that an 
efficient protective Th1 immune response could develop in these 
mice in absence of IL-4Rα signaling.
Mice Deficient in il-4rα signaling in 
Keratinocytes are capable to Mount a Th1 
cell response following L. major infection
To further investigate in details if IL-4Rα signaling in keratino-
cytes impacted Th1 cell differentiation during cutaneous leish-
maniasis, KRT14CreIL-4Rα−/lox mice and control IL-4Rα−/lox were 
infected with 104 L. major (LV39). Four weeks after infection, the 
frequency of IFNγ and IL-4 producing cells was analyzed by flow 
cytometry at the site of infection. A high frequency of CD4+IFNγ+ 
was detected in the ear dermis of KRT14CreIL-4Rα−/lox mice, with 
no difference compared to that measured in similarly infected 
IL-4Rα−/lox control mice (Figure  3A). Only very low levels of 
CD45+CD4+IL-4+ cells were detected in both groups (Figure 3B). 
The frequency of CD4+IFNγ+ cells observed in dLN cells of both 
groups of mice was also similar (Figure 3C) and more elevated 
than the frequency of CD45+CD4+IL-4+ cells observed in dLN 
cells (Figure 3D) revealing that the CD4+ Th1 cells are able to 
differentiate in absence of IL-4Rα signaling in keratinocytes.
FigUre 3 | Absence of IL-4Rα signaling selectively on keratinocytes does not impair T helper (Th) 1 cell differentiation. (a,B) KRT14creIL-4Rα−/lox, IL-4Rα−/lox were 
infected i.d. in the ear pinna with 104 Leishmania major parasites in the ear dermis. Seven weeks postinfection, the frequency of CD4+IFNγ+ and CD4+IL-4+ T cells at 
the site of infection (ears) was analyzed by flow cytometry. (c,D) Similar analysis was performed on draining lymph node cells at the same time point p.i. (e) Serum 
from these mice was analyzed and compared to that of BALB/c mice similarly infected for the presence of L. major-specific IgG2c and (F) IgG1. Data shown are 
representative of two independent experiments.
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In line with the elevated levels of IFNγ detected at the site 
of infection and in dLN cells, high levels of serum IgG2c were 
observed in KRT14CreIL-4Rα−/lox and control IL-4Rα−/lox mice 
(Figure 3E). BALB/c mice showed elevated levels of IgG1, correlat-
ing with the high production of IL-4 observed in their CD4+ T cells, 
while sera from KRT14CreIL-4Rα−/lox and control mice did not 
show significant IgG1 levels (Figure 3F), in line with the absence 
of Th2 cells detected in dLN and at the site of infection. Similar 
data were obtained following s.c. infection in the footpads with a 
higher dose of parasites (2 × 105 L. major, data not shown). Taken 
together, these results show that the absence of IL-4Rα signaling in 
keratinocytes does not impair the development of a protective Th1 
type of immune response during early L. major infection.
Detection of il-4 expressing cells in the 
ear Dermis of c57Bl/6 Mice 1 Day after  
L. major infection
The lack of impact of IL-4Rα signaling on lesion development, 
parasite control, and the differentiation of CD4+ Th1 cells at the 
site of infection and in the dLN firmly demonstrated that IL-4 
signaling on keratinocytes was not involved in Th1 cell differen-
tiation following L. major infection. However, it did not rule out 
an early role for keratinocyte-derived IL-4 in Th1 cell differentia-
tion. To visualize the presence of il-4 mRNA expressing cells in 
the mouse ear dermis cells of L. major-infected mice, we used 
the bicistronic IL-4 reporter (4get) mice on the C57BL/6 genetic 
background (22). We first determined if il-4 mRNA expression 
was detectable in naive ear skin of C57BL/6 mice. A clear e-GFP-
positive population was observed selectively in the CD45+ hemat-
opoietic population. These cells did not express CD11b at their 
cell surface and stained positive for c-kit, a marker specific for 
mast cells (Figure 4A). Further analysis by imaging flow cytom-
etry confirmed that the e-GFP il-4-expressing cells corresponded 
to mast cells characterized by the expression of CD45, the lack 
of expression of CD11b, their large size (average of 14.5 µm of 
diameter) and the presence of numerous granules (Figure 4B). 
We then analyzed the modulation of il-4 mRNA expressing 
cells 4 and 16 h following i.d. infection with L. major, at a time 
when expression of il-4 mRNA by keratinocytes was reported to 
be the highest following subcutaneous infection in the footpad 
(21). No e-GFP+ cells were detectable in the CD45-negative 
FigUre 4 | Mast cells express il-4 in naive and Leishmania major-infected ears of C57BL/6 mice. (a) C57BL/6 4get mice were inoculated i.d. into the right ear with 
2 × 105 metacyclic L. major. Ears were recovered 4 or 16 h p.i. processed and analyzed by flow cytometry for e-GFP, CD45, CD11b and c-kit surface expression. 
As negative controls, naïve ears were also isolated and similarly processed (B). Four hours postinfection, ears were similarly processed, stained with CD45 and 
CD11b, and analyzed by imaging flow cytometry. The e-GFP positive cells were all CD45+CD11b−, and showed a high granulosity (SSC) and a bright field 
phenotype typical of mast cells. A representative picture is shown. n.s: non-significant. (c) Frequency of e-GFP positive cells among total ear cells for 4get C57BL/6 
at 0 (naïve), 4, or 16 h (▲) p.i. The data are pooled from three independent experiments.
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cell population, suggesting that keratinocytes did not express 
detectable levels of il-4 mRNA at the time analyzed. Mast cells 
were the only cell population where il-4 mRNA, as assessed by 
e-GFP expression, was detectable 4 and 16 h p.i. (Figure 4A lower 
panels). The frequency of e-GFP+ cell (approximately 1.5% of 
total ear cells) between infected and the contralateral uninfected 
ear was analyzed for each mouse. It did not vary between infected 
and uninfected ears at the analyzed time points (Figure  4C). 
These data show that most of the il-4 mRNA expressing cells in 
the ear during the first 16 h post infection are mast cells and that 
L. major does not modulate il-4 mRNA expression in these cells 
early during infection.
Mast cells Do not Produce il-4 upon  
L. major infection
Mast cells appeared to be the major dermal cells expressing IL-4 
early after infection, suggesting that this source of IL-4 could play 
a role locally. To visualize IL-4 cytokine production, C57BL/6 
KN2 (knockin huCD2) IL-4 reporter mice that specifically report 
the production of IL-4 protein were used. Cells producing IL-4 
express a fragment of the human CD2 molecule at the cell surface 
making it easily detectable by flow cytometry (23). We crossed 
these KN2 mice with 4get mice to simultaneously detect IL-4 
expression and production. First, to ensure that digestion of the 
ear would not impact IL-4 detection, KN2/4get mice, all on the 
C57BL/6 genetic background, were treated with anti-IFNγ and 
anti-IL-12 mAbs at the onset of infection to induce Th2 cell dif-
ferentiation. Four weeks post infection, ears from mAb-depleted 
or control mice were isolated, processed, and analyzed by flow 
cytometry. Treatment with anti-IFNγ and anti-IL-12 promoted 
the differentiation of Th2 cells. il-4 mRNA expression (e-GFP+ 
cells) and IL-4 protein production (detected by hCD2 expres-
sion) were easily detectable (7.9%) in the ear dermis of CD4+ 
T cells (Figures 5A,C). Minimal IL-4 expression or production 
(0.4%) was detectable in ear cells of similarly infected KN2/4get 
mice treated with a control mAb (Figure  5B) in line with the 
differentiation of Th1 cells in these mice. 4get/KN2 naïve ears 
(0  h p.i.) showed detectable il-4 mRNA expression in CD45+ 
but not in CD45− cells and no IL-4 proteins as no huCD2+ cells 
were detected in either population, suggesting a lack of IL-4 
production (Figure 5D). Infection did not change the frequency 
of cells transcribing il-4 and no IL-4 production was observed 
12 and 24 h after L. major infection (Figures 5E–G). These data 
suggest that ear skin mast cells transcribe the il-4 gene but do 
not produce detectable IL-4 proteins at steady-state conditions, 
and L. major does not induce IL-4 production in the ear dermis 
early during infection.
Taken together, these results demonstrate that during the first 
hours of infection, il-4 gene expression can be detected at the 
FigUre 5 | IL-4 production is not detectable locally during the first hours of Leishmania infection in mice on the C57BL/6 genetic background. (a) C57BL/6 
KN2/4get mice were injected intraperitoneally with anti-IFNγ and anti-IL-12 24 and 2 h before and 48 h after infection with 2 × 105 Leishmania major i.d. in the ear. 
Four weeks p.i. ears were isolated and digested prior to labeling with anti-CD4 and anti-CD8 mAbs. CD4+ T cells were analyzed for the expression of il-4 detected 
by e-GFP and protein production of IL-4 detected by surface staining with a huCD2 mAb. (B) C57BL/6 KN2/4get mice were similarly infected but injected with an 
isotype control mAb at the onset of infection. Four weeks postinfection, IL-4 expression and production were analyzed by detection of e-GFP and huCD2 staining, 
respectively. (c) Bar graph gives the frequency of CD45+CD4+eGFP+hCD2+ cells (means ± SD of 3–5 animals per group) *p < 0.05. These are representative of 
three experiments. (D–F) C57BL/6 KN2/4get mice were inoculated into the right ear with 2 × 105 metacyclic L. major. Ears were recovered 0, 12, and 24 h p.i., 
processed, and stained with CD45, human CD2, or its isotype control mAbs and analyzed by flow cytometry to detect the expression (e-GFP) and production 
(huCD2+) of IL-4. Representative flow cytometry profiles are shown (D–F) and (g) the bar graph shows the frequency of e-GFP+CD45+ and e-GFP+CD45− cells 
(mean ± SD of 4 animals per group). Data are representative of three experiments.
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infection site selectively in mast cell, but il-4 mRNA expression 
was not modulated during L. major infection (analyzed at 0, 
4,12,16, and 24 h p.i.). Furthermore, no IL-4 protein production 
was detectable in the ear dermis during the first 24 h after L. major 
infection.
local neutralization of il-4 Does not 
impair Th1 Development in response  
to L. major infection
To further investigate if skin-derived IL-4 played a role in 
Th1 cell differentiation, C57BL/6 wild-type mice were infected 
FigUre 6 | Neutralization of IL-4 prior to infection with Leishmania major i.d. does not impact T helper (Th) 1 immune response. (a) Neutralization of IL-4 strategy. 
The anti-IL-4 mAb (11B11) or an isotype control mAb was injected intradermally simultaneously with the infection of 2 × 105 metacyclic L. major in the ear dermis. 
Four hours later, another injection of anti-IL-4 was given i.d. T helper immune response was analyzed 14 days later. (B) Two weeks postinfection, cervical draining 
lymph node (dLN) cells were recovered. The levels of IFNγ and IL-4 were assessed by intracellular staining and analyzed by flow cytometry. A representative plot is 
shown. (c) The levels of IFNγ and IL-4 secretion was quantified by ELISA in supernatants of dLN cells restimulated with UV-irradiated L. major. Mean cytokine 
expression ± SEM is given (n ≥ 3 mice per group). The data are pooled from two independent experiments. (D) Parasite load in the ear analyzed by limiting 
dilution assay 2 weeks p.i. Data presented as mean ± SEM (n ≥ 3 mice per group). Data shown are representative of two independent experiments. n.s: 
non-significant.
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with 2 × 105 L. major in the ear dermis following the protocol 
described in Figure  6A, which is similar to that described 
previously (21). Two weeks post infection, the frequency of 
CD4+IFNγ+ and CD4+IL-4+ dLN T cells represented in average 
0.6 and 0.13% of total CD4+ T cells, respectively. These values 
were similar to those obtained in mice similarly infected but 
treated with a control mAb (Figure 6B). The levels of IFNγ and 
IL-4 secretion in dLN cells stimulated ex vivo with UV-treated 
L. major 2 weeks after infection also showed no significant dif-
ferences between the anti-IL-4 and control groups (Figure 6C). 
In line with these data, no difference in parasite load was 
observed between groups depleted or not of IL-4 at the onset 
of infection (Figure  6D). These results show that neutraliza-
tion of IL-4 locally in the ear dermis during the first hours of 
infection at the site of infection does not have an impact on the 
development of the Type-1 immune response during cutaneous 
leishmaniasis.
DiscUssiOn
The study of the early events leading to the differentiation of Th1 
or Th2 cells is of importance and has relevance in the design of 
vaccines generated against pathogens inducing a specific Th type 
of immune response. IL-4 and its signaling through interaction 
with the IL-4/IL-13 receptor has been described as an important 
cytokine favoring the differentiation of CD4+ Th2 cells and 
type 2 immunity (30). However, several lines of evidence sug-
gest that IL-4 may also be involved in Th1  cell differentiation 
(15–18, 31, 32). In this line, it was reported that following s.c. 
injection in the hind footpad of a very high dose (2 ×  107) of 
L. major parasites, keratinocytes transiently upregulated il4 
mRNA mostly within the first 16  h of infection. Blocking of 
IL-4 at the infection site impaired IFNγ secretion by dLN T cells 
7  days later and increased IL-4 secretion by dLN cells 1  week 
post infection (21).
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In an attempt to analyze if early after L. major inoculation, 
IL-4 secretion by keratinocytes could act in an autocrine way on 
these cells locally during the first days of infection, we generated 
mice genetically deficient in the IL-4Rα on keratinocytes. IL-4Rα 
hemizygosity (-/lox) was used to increase the probability of the 
floxed allele deletion by the Cre recombinase (24). IL-4 was pre-
viously shown to act on structural components of keratinocytes 
in vitro, a process that could be linked to epidermal structural 
problems (33). We show here that naive KRT14CreIL-4Rα−/lox mice 
are viable and have a normal phenotype. Upon infection with 
L. major i.d. in the ear pinna with a low or with a higher dose of 
parasites, mice with impaired IL-4Rα signaling on keratinocytes 
were able to resolve their cutaneous lesion, develop protective 
Th1 cells, and control parasite load. Similar data were obtained 
following infection of a higher dose of L. major subcutaneously 
in the footpad. These data demonstrate that following L. major 
infection IL-4Rα signaling in keratinocyte does not impair wound 
healing and is not required for the development of a protective 
type-1 immune response.
To directly visualize if IL-4 expression was induced in 
keratinocytes following infection with L. major, we used the well 
characterized IL-4-GFP reporter 4get mice (22). We detected 
il-4-transcribing cells in the ear dermis of naïve C57BL/6 mice 
and the majority of the positive cells were mast cells and not 
keratinocytes. Mast cells are tissue-resident cells and it was previ-
ously reported that mast cells from BALB/c mice constitutively 
express il4 mRNA at steady state (34). The detection of e-GFP+  
(il-4 transcribing) mast cells in naïve ears detected here is thus in 
line with this study. Mast cell stimulation is required for these cells 
to secrete IL-4 protein. To verify if stimulated mast cells could be 
the source of the early IL-4 putatively present in C57BL/6 skin of 
L. major-infected mice, we used the KN2 reporter mice on the 
C57BL/6 genetic background, which allow the visualization of 
cells that produce IL-4 protein (23). Mast cells did not produce 
detectable IL-4 levels upon L. major infection within the first 24 h 
p.i. in KN2 mice. It was previously reported that C57BL/6 mice 
deficient in mast cells (C57BL/6 CpaCre) were perfectly able to 
mount a Th1 type of cell immune response following L. major 
infection (35). Together with our study, these results rule out a 
role for early mast cell-derived IL-4 in driving Th1 cell differen-
tiation and resolution of lesion size and parasite load following 
L. major infection. In addition, il4 transcription was not detect-
able in keratinocytes during the first day of L. major infection.
It cannot be excluded that a few cells may locally express 
il-4 at low levels at steady state or upon L. major infection and 
that these cells were not detectable using L. major-infected 4get 
mice. Nevertheless, as no detectable IL-4-producing cells were 
observed in the skin of infected KN2 mice the possibility of IL-4 
driving Th1 differentiation following infection with L. major is 
rather unlikely.
Several factors may explain the differences observed between 
the present report and previous studies reporting a role for IL-4 in 
Th1 differentiation following L. major infection. First, the parasite 
dose injected differed in the two studies. Ehrchen et al. reported 
il-4 mRNA expression by keratinocytes during the first day after 
infection with a vey high dose (2 × 107) of L. major inoculated 
s.c. in the hind footpad (21). During their blood meal, sand flies 
deposit a much lower number of parasites ranging from 10–104 
and it was shown that the size of the parasite inoculum can have 
an impact on the immune response (36). Here, following infec-
tion of reporter mice with 2 × 105 L. major, no detectable levels 
of il4 mRNA or IL-4 proteins were locally measured during the 
first days of infection. The parasite dose injected here is 100 times 
lower than that used in the study by Ehrchen et al., potentially 
explaining the differences observed. In addition, here, we used 
infective metacyclic L. major rather than stationary phase para-
sites to infect mice. Furthermore, the sensitivity of the microarray 
analysis used in the study by Ehrchen et al. is higher than that of 
the reporter system used here, as qPCR analysis can detect minute 
amounts of il-4 mRNA. The absence of IL-4 proteins detected 
here suggests that if some IL-4 is produced locally following i.d. 
inoculation of parasites, it is in very low quantities.
A second major difference between the two studies is the site 
of parasite inoculation. Here, L. major was inoculated in the ear 
dermis, while in the Ehrchen’s study it was injected subcutane-
ously in the hind footpad. Recruitment of innate cells to the site 
of infection was recently shown to differ whether L. major was 
inoculated in the hind footpad or in the ear dermis of mice, with 
a distinct impact on the local microenvironment at the site of 
infection (29). However, here, we show that irrespective of the site 
of infection, the absence of IL-4Rα on keratinocytes in L. major-
infected mice did not have any impact on lesion development and 
immune response.
Distinct Leishmania species elicit different immune response. 
In addition, distinct L. major strains also have diverse virulence 
[reviewed in Ref. (28)]. This could have explained the differences 
observed in the two studies. However, mice on the C57BL/6 
genetic background with total abrogation of IL-4Rα on all cells 
were fully able to control lesion size and parasite load following 
either intradermal or subcutaneous infection with 2 × 105 L. major 
of two different strains (LV39 or IR81), a process correlating with 
the development of functional Th1 cells in response to infection 
(here and unpublished data). Collectively, these data suggest that 
the difference observed in the two studies may not result from 
differences in the site of parasite inoculation or L. major strain 
virulence but rather come from differences in the parasite dose 
inoculated.
Distinct skin microbiota present in different animal facilities 
may also explain the differences observed between the previous 
and the present study as microbiota was shown to affect the 
immune response (37). This is, however, unlikely to be the expla-
nation as the data presented here were obtained in two distinct 
laboratories with similar results. Furthermore, despite repeated 
attempts of blocking IL-4 locally using different parasite inocula-
tion dose and injection scheme of anti-IL-4 mAb as well as distinct 
L. major parasite strains (here and unpublished data) we could not 
detect an impact of IL-4 blockade on the immune response and 
parasite control between 14 and 21 days post infection.
Another study reported the importance of early IL-4 in CD4+ 
Th1 differentiation (16). In this study, BALB/c mice infected 
with 2  ×  105 L. major LV39 stationary phase promastigotes 
were treated with recombinant IL-4 at the time and 8  h post 
L. major infection. Administration of a relatively high dose (1 µg) 
but not of a lower dose (0.1 µg) of IL-4 instructed resistance in 
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these otherwise L. major susceptible BALB/c mice. One major 
difference with the present study is that BALB/c mice were used 
in that study. Furthermore, the dose of IL-4 injected locally may 
not correspond to cytokine levels present at the site of infection 
in L. major-infected C57BL/6 mice. If such levels of IL-4 protein 
had been present locally, it would have been detected here using 
the IL-4 reporter mice. Collectively, these and our data suggest 
that the early presence of IL-4 may have a different impact on the 
development of Th1 response depending on the dose of parasite 
inoculated, the genetic background of the mice, and the local 
amount of IL-4 protein present at the site of infection.
Altogether, our data provide strong evidence that IL-4 signal-
ing in keratinocytes at the site of infection or in general, is 
not required for the differentiation of Th1  cells following 
L. major infection and that IL-4 protein production at the onset of 
infection is not required for Th1 cell differentiation in L. major-
infected C57BL/6 mice.
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